Irish patients not getting access to new medicines quickly enough says IPHA

The pharmaceutical industry claims that Irish patients are not getting access to new medicines quickly enough.

The Irish Pharmaceutical Healthcare Association says Ireland has the worst record in Europe when it comes to adopting new drugs.

The IPHA is discussing the issue at its annual conference today in Dublin.

Phillip Hannon from the IPHA says the method for deciding which drugs will be funded through by the HSE is too slow.

He said: "It is the processes that we have in terms of the reimbursement periods, the processs are wrong and I think need to be looked at.

"The minister himself said on the record in the Dail that the reimbursement system is broken."

Related Articles

Latest: Islamic Centre of Ireland trying to give Muslims confidence to say no to Female Genital Mutilation

Scientists say skin supplements could be a waste of money

Varadkar accused of 'scapegoating' GPs for hospital overcrowding

Calls for reform as revealed 40,000 now waiting for outpatient eye-care

More in this Section

Labour MP to introduce Northern Ireland same-sex marriage bill in March

DUP 'unaware' of money for legacy inquests

Fugitive solicitor Michael Lynn loses challenge over DPP assurances in extradition process

Guatemalan mother caught with cocaine-soaked shirts valued at €179k jailed for three years


Today's Stories

€160m Cork docklands plan cleared for development

€22bn green plan but TDs drive diesel

New cancer treatment to reduce radiation risk to heart

Cork one of cities worst-hit if globe heats up

Lifestyle

The biggest cancer killer will take your breath away

Hopefully she had an idea...

Power of the press: Meryl Streep and Tom Hanks discuss 'The Post'

More From The Irish Examiner